Skip to main content
Premium Trial:

Request an Annual Quote

Harvard Bioscience Acquires British Spectrophotometer Maker

NEW YORK, July 2 - A Harvard Bioscience subsidiary said yesterday it has acquired British spectrophotometer maker Walden Precision Apparatus for an undisclosed amount.


A spokesperson said that as Walden leaves its Linton, UK, base to join its new parent, Biochrom, in neighboring Cambridge at the end of September, "some employees" will not be asked to stay on. The spokesman, David Green, would not elaborate.


Walden Precision primary designs, manufactures and markets a line of inexpensive diode-array spectrophotometers. Biochrom hopes that acquiring the line will bolster its own range of mid- and high-end spectrophotometers.


Though Biochrom's own line of spectrophotometers is sold worldwide by Amersham Biosciences, the Harvard Bioscience unit said it may enlist the help of Walden's distributors to sell the recently released mid-range tools.


Harvard Bioscience said the acquisition, in the works for between three and six months, would contribute about $750,000 in revenues this year and as much as $2 million in 2003.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.